HSTO News and Press, Histogen Inc. From 07/05/23

SAN DIEGO, July 05, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class clinical and preclinical small molecule pan-caspase and caspase selective inhibitors that protect the body’s natural process to re...

2023-05-11 16:57:29 ET Histogen press release ( NASDAQ: HSTO ): Q1 GAAP EPS of -$0.81. Revenues for the three months ended March 31, 2023 and 2022, we recognized license revenue of $5 thousand and $3.8 million, respectively. Research and development expenses for t...

Received FDA Clearance of IND Application for Emricasan for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Emricasan Treatment has Therapeutic Effect Against Bacterial Skin Infection in Mice Signed Exclusive Intellectual Property License Agreement w...

Emricasan Treatment has Therapeutic Effect Against Bacterial Skin Infection in Mice Pipeline Focus on Pan-Caspase and Caspase Selective Inhibitors for Infectious and Inflammatory Diseases SAN DIEGO, April 20, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (HSTO), a clinical-stage ther...

2023-04-03 17:18:03 ET Histogen ( NASDAQ: HSTO ) on Monday said it had signed an exclusive license agreement with Johns Hopkins University, sending its shares about 5% higher to $1.25 after hours. "The intellectual property associated with this license covers the use of em...

Licensed Patents Expected to Provide Freedom to Operate and Exclusivity for Emricasan Pipeline Focus on Pan-Caspase and Caspase Selective Inhibitors for Infectious and Inflammatory Diseases SAN DIEGO, April 03, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (HSTO), a clinical-stage therapeu...

2023-03-20 06:00:00 ET 3 Sectors to Find Penny Stocks That Could Be Worth Buying Navigating the vast landscape of penny stocks can be an exciting venture for investors looking to capitalize on hidden gems. Although these stocks are often seen as risky due to their low price, they can of...

2023-03-18 06:00:00 ET 3 Tips for Making Money With Penny Stocks in 2023 As an investor looking to succeed with penny stocks , it’s essential to develop a winning mindset that will enable you to make the most out of small-cap investments in 2023. One of the keys to success in...

The Newly Issued Patent is Expected to Provide Protection into 2040 Pipeline Focus on Pan-Caspase and Caspase Selective Inhibitors for Infectious and Inflammatory Diseases SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics compa...

2023-03-09 16:59:55 ET Histogen press release ( NASDAQ: HSTO ): FY GAAP EPS of -$3.46. Revenue of $3.77M (+266.0% Y/Y) misses by $0.35M . For further details see: Histogen GAAP EPS of -$3.46, revenue of $3.77M misses by $0.35M